Inhibition of APE1 Expression Enhances the Antitumor Activity of Olaparib in Triple-Negative Breast Cancer.
Evid Based Complement Alternat Med
; 2022: 6048017, 2022.
Article
in En
| MEDLINE
| ID: mdl-35463096
Full text:
1
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Evid Based Complement Alternat Med
Year:
2022
Type:
Article
Affiliation country:
China